Global and China Kidney Disease Drugs Market Insights, Forecast to 2027
SKU ID : QYR-19209655 | Publishing Date : 23-Sep-2021 | No. of pages : 152
Detailed TOC of Global and China Kidney Disease Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Kidney Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Kidney Disease Drugs Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Kidney Disease Drugs Market Size Growth Rate by Application
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Kidney Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Kidney Disease Drugs Revenue 2016-2027
2.1.2 Global Kidney Disease Drugs Sales 2016-2027
2.2 Global Kidney Disease Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Kidney Disease Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Kidney Disease Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Kidney Disease Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027)
3 Global Kidney Disease Drugs Competitor Landscape by Players
3.1 Global Top Kidney Disease Drugs Manufacturers by Sales
3.1.1 Global Kidney Disease Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Kidney Disease Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Kidney Disease Drugs Manufacturers by Revenue
3.2.1 Key Kidney Disease Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Kidney Disease Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Kidney Disease Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Kidney Disease Drugs Revenue in 2020
3.2.6 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Kidney Disease Drugs Price by Manufacturers
3.4 Global Kidney Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Kidney Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Kidney Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Kidney Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Kidney Disease Drugs Market Size by Type (2016-2021)
4.1.1 Global Kidney Disease Drugs Sales by Type (2016-2021)
4.1.2 Global Kidney Disease Drugs Revenue by Type (2016-2021)
4.1.3 Kidney Disease Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Kidney Disease Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Kidney Disease Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Kidney Disease Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Kidney Disease Drugs Market Size by Application (2016-2021)
5.1.1 Global Kidney Disease Drugs Sales by Application (2016-2021)
5.1.2 Global Kidney Disease Drugs Revenue by Application (2016-2021)
5.1.3 Kidney Disease Drugs Price by Application (2016-2021)
5.2 Kidney Disease Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Kidney Disease Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Kidney Disease Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Kidney Disease Drugs Market Size YoY Growth 2016-2027
6.1.1 China Kidney Disease Drugs Sales YoY Growth 2016-2027
6.1.2 China Kidney Disease Drugs Revenue YoY Growth 2016-2027
6.1.3 China Kidney Disease Drugs Market Share in Global Market 2016-2027
6.2 China Kidney Disease Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Kidney Disease Drugs Players by Sales (2016-2021)
6.2.2 China Top Kidney Disease Drugs Players by Revenue (2016-2021)
6.3 China Kidney Disease Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Kidney Disease Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Kidney Disease Drugs Price by Type (2016-2021)
6.4 China Kidney Disease Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Kidney Disease Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Kidney Disease Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Kidney Disease Drugs Price Forecast by Type (2022-2027)
6.5 China Kidney Disease Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Kidney Disease Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Kidney Disease Drugs Price by Application (2016-2021)
6.6 China Kidney Disease Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Kidney Disease Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Kidney Disease Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Kidney Disease Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Kidney Disease Drugs Market Size YoY Growth 2016-2027
7.2 North America Kidney Disease Drugs Market Facts & Figures by Country
7.2.1 North America Kidney Disease Drugs Sales by Country (2016-2021)
7.2.2 North America Kidney Disease Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Kidney Disease Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Kidney Disease Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Kidney Disease Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Kidney Disease Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Kidney Disease Drugs Market Size YoY Growth 2016-2027
9.2 Europe Kidney Disease Drugs Market Facts & Figures by Country
9.2.1 Europe Kidney Disease Drugs Sales by Country (2016-2021)
9.2.2 Europe Kidney Disease Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Kidney Disease Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Kidney Disease Drugs Market Facts & Figures by Country
10.2.1 Latin America Kidney Disease Drugs Sales by Country (2016-2021)
10.2.2 Latin America Kidney Disease Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Kidney Disease Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Kidney Disease Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Kidney Disease Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Kidney Disease Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Kidney Disease Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Kidney Disease Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Kidney Disease Drugs Products Offered
12.3.5 Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Kidney Disease Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Description and Business Overview
12.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Kidney Disease Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Keryx Biopharmaceuticals
12.6.1 Keryx Biopharmaceuticals Corporation Information
12.6.2 Keryx Biopharmaceuticals Description and Business Overview
12.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Products Offered
12.6.5 Keryx Biopharmaceuticals Recent Development
12.7 Kissei Pharmaceutical
12.7.1 Kissei Pharmaceutical Corporation Information
12.7.2 Kissei Pharmaceutical Description and Business Overview
12.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kissei Pharmaceutical Kidney Disease Drugs Products Offered
12.7.5 Kissei Pharmaceutical Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Description and Business Overview
12.8.3 AbbVie Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AbbVie Kidney Disease Drugs Products Offered
12.8.5 AbbVie Recent Development
12.9 Amgen
12.9.1 Amgen Corporation Information
12.9.2 Amgen Description and Business Overview
12.9.3 Amgen Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Amgen Kidney Disease Drugs Products Offered
12.9.5 Amgen Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Corporation Information
12.10.2 Teva Pharmaceutical Industries Description and Business Overview
12.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Kidney Disease Drugs Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
12.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
12.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
12.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Products Offered
12.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
12.13 Datong Liqun Pharmaceutical
12.13.1 Datong Liqun Pharmaceutical Corporation Information
12.13.2 Datong Liqun Pharmaceutical Description and Business Overview
12.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Datong Liqun Pharmaceutical Products Offered
12.13.5 Datong Liqun Pharmaceutical Recent Development
12.14 Hebei Ruisen Pharmaceutical
12.14.1 Hebei Ruisen Pharmaceutical Corporation Information
12.14.2 Hebei Ruisen Pharmaceutical Description and Business Overview
12.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Hebei Ruisen Pharmaceutical Products Offered
12.14.5 Hebei Ruisen Pharmaceutical Recent Development
12.15 Changxing Pharmaceutical
12.15.1 Changxing Pharmaceutical Corporation Information
12.15.2 Changxing Pharmaceutical Description and Business Overview
12.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Changxing Pharmaceutical Products Offered
12.15.5 Changxing Pharmaceutical Recent Development
12.16 zhejiang Shengbokang Pharmaceutical
12.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
12.16.2 zhejiang Shengbokang Pharmaceutical Description and Business Overview
12.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 zhejiang Shengbokang Pharmaceutical Products Offered
12.16.5 zhejiang Shengbokang Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Kidney Disease Drugs Industry Trends
13.2 Kidney Disease Drugs Market Drivers
13.3 Kidney Disease Drugs Market Challenges
13.4 Kidney Disease Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Kidney Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Kidney Disease Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Kidney Disease Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Other
Table 5. Global Kidney Disease Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Kidney Disease Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Kidney Disease Drugs Sales by Regions (2016-2021) & (K Units)
Table 8. Global Kidney Disease Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Kidney Disease Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Kidney Disease Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Kidney Disease Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Kidney Disease Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Kidney Disease Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Kidney Disease Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Kidney Disease Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Kidney Disease Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Kidney Disease Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Disease Drugs as of 2020)
Table 21. Key Manufacturers Kidney Disease Drugs Price (2016-2021) (US$/Unit)
Table 22. Kidney Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Kidney Disease Drugs Product Type
Table 24. Date of International Manufacturers Enter into Kidney Disease Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Kidney Disease Drugs Sales by Type (2016-2021) (K Units)
Table 27. Global Kidney Disease Drugs Sales Share by Type (2016-2021)
Table 28. Global Kidney Disease Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Kidney Disease Drugs Revenue Share by Type (2016-2021)
Table 30. Kidney Disease Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Kidney Disease Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Kidney Disease Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Kidney Disease Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Kidney Disease Drugs Sales by Application (2016-2021) (K Units)
Table 37. Global Kidney Disease Drugs Sales Share by Application (2016-2021)
Table 38. Global Kidney Disease Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Kidney Disease Drugs Revenue Share by Application (2016-2021)
Table 40. Kidney Disease Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Kidney Disease Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Kidney Disease Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Kidney Disease Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Kidney Disease Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Kidney Disease Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Kidney Disease Drugs Sales (K Units) of Key Companies (2016-2021)
Table 47. China Kidney Disease Drugs Sales Share by Company (2016-2021)
Table 48. China Kidney Disease Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China Kidney Disease Drugs Revenue Share by Company (2016-2021)
Table 50. China Kidney Disease Drugs Sales (K Units) by Type (2016-2021)
Table 51. China Kidney Disease Drugs Sales Share by Type (2016-2021)
Table 52. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Kidney Disease Drugs Price (US$/Unit) by Type (2016-2021)
Table 54. China Kidney Disease Drugs Sales (K Units) by Type (2022-2027)
Table 55. China Kidney Disease Drugs Sales Share by Type (2022-2027)
Table 56. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Kidney Disease Drugs Revenue Share by Type (2022-2027)
Table 58. China Kidney Disease Drugs Price (US$/Unit) by Type (2022-2027)
Table 59. China Kidney Disease Drugs Sales (K Units) by Application (2016-2021)
Table 60. China Kidney Disease Drugs Sales Share by Application (2016-2021)
Table 61. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Kidney Disease Drugs Price (US$/Unit) by Application (2016-2021)
Table 63. China Kidney Disease Drugs Sales (K Units) by Application (2022-2027)
Table 64. China Kidney Disease Drugs Sales Share by Application (2022-2027)
Table 65. China Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Kidney Disease Drugs Revenue Share by Application (2022-2027)
Table 67. China Kidney Disease Drugs Price (US$/Unit) by Application (2022-2027)
Table 68. North America Kidney Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 69. North America Kidney Disease Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Kidney Disease Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Kidney Disease Drugs Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Kidney Disease Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Kidney Disease Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Kidney Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 77. Europe Kidney Disease Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Kidney Disease Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Kidney Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Kidney Disease Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Kidney Disease Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Kidney Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Kidney Disease Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country (2016-2021)
Table 88. GlaxoSmithKline Corporation Information
Table 89. GlaxoSmithKline Description and Business Overview
Table 90. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. GlaxoSmithKline Kidney Disease Drugs Product
Table 92. GlaxoSmithKline Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Business Overview
Table 95. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. Roche Corporation Information
Table 99. Roche Description and Business Overview
Table 100. Roche Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Roche Product
Table 102. Roche Recent Development
Table 103. Pfizer Corporation Information
Table 104. Pfizer Description and Business Overview
Table 105. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Pfizer Product
Table 107. Pfizer Recent Development
Table 108. AstraZeneca Corporation Information
Table 109. AstraZeneca Description and Business Overview
Table 110. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. AstraZeneca Product
Table 112. AstraZeneca Recent Development
Table 113. Keryx Biopharmaceuticals Corporation Information
Table 114. Keryx Biopharmaceuticals Description and Business Overview
Table 115. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Keryx Biopharmaceuticals Product
Table 117. Keryx Biopharmaceuticals Recent Development
Table 118. Kissei Pharmaceutical Corporation Information
Table 119. Kissei Pharmaceutical Description and Business Overview
Table 120. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Kissei Pharmaceutical Product
Table 122. Kissei Pharmaceutical Recent Development
Table 123. AbbVie Corporation Information
Table 124. AbbVie Description and Business Overview
Table 125. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. AbbVie Product
Table 127. AbbVie Recent Development
Table 128. Amgen Corporation Information
Table 129. Amgen Description and Business Overview
Table 130. Amgen Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Amgen Product
Table 132. Amgen Recent Development
Table 133. Teva Pharmaceutical Industries Corporation Information
Table 134. Teva Pharmaceutical Industries Description and Business Overview
Table 135. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Teva Pharmaceutical Industries Product
Table 137. Teva Pharmaceutical Industries Recent Development
Table 138. Tianjin Tongrentang Group Corporation Information
Table 139. Tianjin Tongrentang Group Description and Business Overview
Table 140. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Tianjin Tongrentang Group Product
Table 142. Tianjin Tongrentang Group Recent Development
Table 143. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
Table 144. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Description and Business Overview
Table 145. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Product
Table 147. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development
Table 148. Datong Liqun Pharmaceutical Corporation Information
Table 149. Datong Liqun Pharmaceutical Description and Business Overview
Table 150. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Datong Liqun Pharmaceutical Product
Table 152. Datong Liqun Pharmaceutical Recent Development
Table 153. Hebei Ruisen Pharmaceutical Corporation Information
Table 154. Hebei Ruisen Pharmaceutical Description and Business Overview
Table 155. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Hebei Ruisen Pharmaceutical Product
Table 157. Hebei Ruisen Pharmaceutical Recent Development
Table 158. Changxing Pharmaceutical Corporation Information
Table 159. Changxing Pharmaceutical Description and Business Overview
Table 160. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Changxing Pharmaceutical Product
Table 162. Changxing Pharmaceutical Recent Development
Table 163. zhejiang Shengbokang Pharmaceutical Corporation Information
Table 164. zhejiang Shengbokang Pharmaceutical Description and Business Overview
Table 165. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. zhejiang Shengbokang Pharmaceutical Product
Table 167. zhejiang Shengbokang Pharmaceutical Recent Development
Table 168. Kidney Disease Drugs Market Trends
Table 169. Kidney Disease Drugs Market Drivers
Table 170. Kidney Disease Drugs Market Challenges
Table 171. Kidney Disease Drugs Market Restraints
Table 172. Kidney Disease Drugs Customers List
Table 173. Kidney Disease Drugs Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Disease Drugs Product Picture
Figure 2. Global Kidney Disease Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Kidney Disease Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Chronic Glomerulonephritis
Figure 8. Nephrotic Syndrome
Figure 9. Chronic Renal Failure
Figure 10. Kidney Stones
Figure 11. Renal Cyst (polycystic Kidney)
Figure 12. Diabetic Nephropathy
Figure 13. Hypertensive Nephropathy
Figure 14. Purpura Nephritis
Figure 15. Lupus Nephritis
Figure 16. Pediatric Kidney Disease
Figure 17. Kidney Disease Drugs Report Years Considered
Figure 18. Global Kidney Disease Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Kidney Disease Drugs Market Size 2016-2027 (US$ Million)
Figure 20. Global Kidney Disease Drugs Sales 2016-2027 (K Units)
Figure 21. Global Kidney Disease Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 22. Global Kidney Disease Drugs Sales Market Share by Region (2016-2021)
Figure 23. Global Kidney Disease Drugs Sales Market Share by Region in 2020
Figure 24. Global Kidney Disease Drugs Revenue Market Share by Region (2016-2021)
Figure 25. Global Kidney Disease Drugs Revenue Market Share by Region in 2020
Figure 26. Global Kidney Disease Drugs Sales Share by Manufacturer in 2020
Figure 27. The Top 10 and 5 Players Market Share by Kidney Disease Drugs Revenue in 2020
Figure 28. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Kidney Disease Drugs Sales Market Share by Type (2016-2021)
Figure 30. Global Kidney Disease Drugs Sales Market Share by Type in 2020
Figure 31. Global Kidney Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 32. Global Kidney Disease Drugs Revenue Market Share by Type in 2020
Figure 33. Global Kidney Disease Drugs Sales Market Share by Application (2016-2021)
Figure 34. Global Kidney Disease Drugs Sales Market Share by Application in 2020
Figure 35. Global Kidney Disease Drugs Revenue Market Share by Application (2016-2021)
Figure 36. Global Kidney Disease Drugs Revenue Market Share by Application in 2020
Figure 37. China Kidney Disease Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 38. China Kidney Disease Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 39. China Kidney Disease Drugs Market Share in Global Market 2016-2027
Figure 40. China 5 and 10 Largest Kidney Disease Drugs Players Market Share by Revenue in Kidney Disease Drugs in 2020
Figure 41. China Kidney Disease Drugs Revenue Share by Type (2016-2021)
Figure 42. China Kidney Disease Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 43. China Kidney Disease Drugs Revenue Share by Application (2016-2021)
Figure 44. China Kidney Disease Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 45. North America Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 46. North America Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. North America Kidney Disease Drugs Sales Market Share by Country in 2020
Figure 48. North America Kidney Disease Drugs Revenue Market Share by Country in 2020
Figure 49. U.S. Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 50. U.S. Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Canada Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 52. Canada Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. Europe Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 54. Europe Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 55. Europe Kidney Disease Drugs Sales Market Share by Country in 2020
Figure 56. Europe Kidney Disease Drugs Revenue Market Share by Country in 2020
Figure 57. Germany Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. Germany Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. France Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. France Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. U.K. Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 62. U.K. Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Italy Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 64. Italy Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Russia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 66. Russia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Asia Pacific Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 68. Asia Pacific Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 69. Asia Pacific Kidney Disease Drugs Sales Market Share by Region in 2020
Figure 70. Asia Pacific Kidney Disease Drugs Revenue Market Share by Region in 2020
Figure 71. China Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. China Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Japan Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. Japan Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. South Korea Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. South Korea Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. India Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. India Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Australia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Australia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Taiwan Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Taiwan Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Indonesia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 84. Indonesia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Thailand Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 86. Thailand Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Malaysia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 88. Malaysia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Philippines Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 90. Philippines Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Vietnam Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 92. Vietnam Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Latin America Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 94. Latin America Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Latin America Kidney Disease Drugs Sales Market Share by Country in 2020
Figure 96. Latin America Kidney Disease Drugs Revenue Market Share by Country in 2020
Figure 97. Mexico Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 98. Mexico Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Brazil Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 100. Brazil Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Argentina Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 102. Argentina Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Middle East and Africa Kidney Disease Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 104. Middle East and Africa Kidney Disease Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 105. Middle East and Africa Kidney Disease Drugs Sales Market Share by Country in 2020
Figure 106. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Country in 2020
Figure 107. Turkey Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 108. Turkey Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Saudi Arabia Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 110. Saudi Arabia Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 111. UAE Kidney Disease Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 112. UAE Kidney Disease Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 113. Kidney Disease Drugs Value Chain
Figure 114. Channels of Distribution
Figure 115. Distributors Profiles
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
Keyplayers in Global and China Kidney Disease Drugs Market Insights, Forecast to 2027
GlaxoSmithKlineSanofi
Roche
Pfizer
AstraZeneca
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical